当前位置:首页 - 行情中心 - 康缘药业(600557) - 财务分析 - 资产负债表

康缘药业

(600557)

  

流通市值:120.67亿  总市值:121.98亿
流通股本:5.78亿   总股本:5.85亿

资产负债表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
流动资产:
货币资金1,969,272,883.321,494,166,187.331,977,320,416.171,473,330,225.17
应收票据及应收账款653,766,073.68660,177,912.42664,315,148.43712,926,236.56
应收账款653,766,073.68660,177,912.42664,315,148.43712,926,236.56
应收款项融资442,229,504.99310,194,767544,792,088.15820,417,037.7
预付款项28,626,350.9885,350,370.6644,429,852.1746,750,026.2
其他应收款合计5,315,921.097,927,617.6412,412,154.3513,350,947.05
存货350,108,245.14361,300,292.35338,605,472.61368,473,901.98
其他流动资产73,361,887.191,893,157.417,626,723.2950,249,227.91
流动资产平衡项目0000
流动资产合计4,049,719,426.383,631,010,304.813,771,501,855.173,687,497,602.57
非流动资产:
长期股权投资4,109,073.554,108,832.174,108,832.174,088,172.3
其他非流动金融资产11,210,107.418,729,806.425,581,468.431,243,255.82
固定资产2,280,740,570.472,341,926,388.892,358,309,047.142,380,801,172.83
在建工程227,250,218.26197,700,912.56134,286,081.8110,567,135.57
无形资产197,380,959.08214,469,762.18216,224,986.01224,204,581.03
开发支出171,701,113.32165,962,371.46168,798,172.2166,673,459.43
商誉58,988,858.1458,988,858.1458,988,858.1458,988,858.14
长期待摊费用14,403,249.0615,280,735.8216,059,721.5917,109,789.14
递延所得税资产46,222,809.1427,461,382.1227,636,912.2615,051,049.21
其他非流动资产55,595,282.7220,228,520.6722,857,441.0321,974,407.29
非流动资产平衡项目0000
非流动资产合计3,067,602,241.143,064,857,570.413,032,851,520.743,030,701,880.76
资产平衡项目0000
资产总计7,117,321,667.526,695,867,875.226,804,353,375.916,718,199,483.33
流动负债:
应付票据及应付账款228,418,638.9204,236,140.05230,337,890.17297,810,893.87
其中:应付票据--7,498,598.3511,269,481.65
应付账款228,418,638.9204,236,140.05222,839,291.82286,541,412.22
合同负债25,165,640.913,837,025.0829,311,766.8646,867,940.71
应付职工薪酬25,726,012.3832,804,820.5425,836,273.7520,383,809.6
应交税费70,666,290.5970,801,663.8168,035,275.7428,873,651.45
其他应付款合计1,238,903,144.531,107,134,987.941,257,292,743.821,161,305,303.18
应付股利--128,611,549.44-
其他流动负债3,257,247.161,791,591.693,796,086.546,092,832.28
流动负债平衡项目0000
流动负债合计1,608,688,119.361,430,606,229.111,614,610,036.881,561,334,431.09
非流动负债:
长期应付款1,925,4901,925,4901,925,4901,925,490
递延收益126,155,318.2876,618,901.0777,965,362.6478,034,636.26
非流动负债平衡项目0000
非流动负债合计128,080,808.2878,544,391.0779,890,852.6479,960,126.26
负债平衡项目0000
负债合计1,736,768,927.641,509,150,620.181,694,500,889.521,641,294,557.35
所有者权益(或股东权益):
实收资本(或股本)584,748,452584,597,952584,597,952584,597,952
资本公积111,793,377.69122,074,041.01122,074,041.0198,131,851.77
减:库存股48,135,01064,698,48064,698,48064,698,480
盈余公积292,813,413.08292,813,413.08292,813,413.08292,813,413.08
未分配利润4,251,576,797.984,064,264,460.333,990,459,077.933,984,788,117.91
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计5,192,797,030.754,999,051,386.424,925,246,004.024,895,632,854.76
少数股东权益187,755,709.13187,665,868.62184,606,482.37181,272,071.22
股东权益平衡项目0000
股东权益合计5,380,552,739.885,186,717,255.045,109,852,486.395,076,904,925.98
负债和股东权益合计7,117,321,667.526,695,867,875.226,804,353,375.916,718,199,483.33
公告日期2024-03-112023-10-262023-07-132023-04-08
审计意见(境内)标准无保留意见
TOP↑